However, a shorter term pharmacological approach to reduce Nox2 activity in atherosclerosis-prone mice with endothelium-specific insulin resistance resulted in a reduction in lipid deposition in the thoraco-abdominal aorta without disruption of the architecture of the arterial wall. This evidence concerns the gene CYBB and atherosclerosis.